Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome. [electronic resource]
Producer: 20130509Description: 223-31 p. digitalISSN:- 1873-7544
- Analysis of Variance
- Angiopoietins -- immunology
- Animals
- Antibodies -- pharmacology
- Anticholesteremic Agents -- therapeutic use
- Arteries -- cytology
- Bromodeoxyuridine
- Cell Movement -- drug effects
- Cells, Cultured
- Disease Models, Animal
- Human Umbilical Vein Endothelial Cells -- cytology
- Humans
- Lectins -- metabolism
- Linear Models
- Male
- Neovascularization, Pathologic -- etiology
- Neovascularization, Physiologic -- drug effects
- Rats
- Rats, Wistar
- Simvastatin -- therapeutic use
- Stroke -- drug therapy
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.